July 30th, 2011 by GarySchwitzer in Opinion
No Comments »
For several years, I’ve been gently nudging various groups that communicate with the public about health care to adopt/endorse/promote the 10 criteria we use on HealthNewsReview.org in the same spirit in which we promote them: 10 things we think consumers need addressed in messages about health care interventions.
• What’s the total cost?
• How often do benefits occur?
• How often do harms occur?
• How strong is the evidence?
• Is this condition exaggerated?
• Are there alternative options?
• Is this really a new approach?
• Is it available to me?
• Who’s promoting this?
• Do they have a conflict of interest?
It may not be a perfect or complete list, but it’s not a bad starting point, and we now have data on more than 1,500 stories showing how these are – or are not – addressed in some of the public discussion.
I’ve urged the American Association of Medical Colleges, America’s Health Insurance Plans, news organizations, and news-release-writers, among others, to publish our criteria attached to their news releases or on their websites.
Many have been called. Many have nodded in agreement. None have responded.
Until now. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
March 18th, 2011 by GarySchwitzer in News, Opinion
No Comments »
A new post on the Embargo Watch blog, “The power of the press release: A tale of two fish oil-chemotherapy studies,” addresses an issue that had me running around in circles for hours last week.
Some news organizations were reporting on a paper in the journal Cancer, reporting that it had been published in that day’s online edition.
But it hadn’t been – not when the stories were published.
Instead, all I could find was a study by the same authors on the same topic that had been published in the same journal two weeks prior.
What apparently happened, as Embargo Watch surmises as well, is that many journalists simply covered what was in the journal’s news release – not what had already been published two weeks prior – which was a more impressive article. And they rushed to publish before the new study had even been posted online – all over a very short-term study in a small number of people. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
March 8th, 2011 by GarySchwitzer in News, Opinion, Research
No Comments »
We’re delighted to see that USA Today, Reuters, and WebMD were among the news organizations that included what an editorial writer said about an observational study linking ibuprofen use with fewer cases of Parkinson’s disease. All three news organizations used some version of what editorial writer Dr. James Bower of the Mayo Clinic wrote or said:
“Whenever in epidemiology you find an association, that does not mean causation.”
“An association does not prove causation.”
“There could be other explanations for the ibuprofen-Parkinson’s connection.”
Kudos to those news organizations. And some praise goes to the journal Neurology for publishing Dr. Bower’s editorial to accompany the study. His piece is entitled, “Is the answer for Parkinson disease already in the medicine cabinet? Unfortunately not.”
And unfortunately not all news organizations got that message. Because many don’t read the journals, so they certainly never get to the editorials. Instead, they rewrite quick hits off a wire service story. As a result, we end up with some of the following:
A FoxNews.com story was particularly deaf to Bower’s caveat, stating: “That bottle of ibuprofen in your medicine cabinet is more powerful than you may think.”
A CBSNews.com story never addressed the observational study limitation, instead whimsically writing: “Pop a pill to prevent Parkinson’s disease? A new study says it’s possible, and the pill in question isn’t some experimental marvel that’s still years away from drugstore shelves. It’s plain old ibuprofen.” Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
December 29th, 2010 by GarySchwitzer in Better Health Network, Health Tips, News, Opinion, Research
No Comments »
Dr. Kent Bottles is in the midst of a very thoughtful multi-part blog post under the heading, “The Difficult Science Behind Becoming a Savvy Healthcare Consumer.”
Part I examined “the limitations of science in helping us make wise choices and decisions about our health.”
Part II explores “how we all have to change if we are to live wisely in a time of rapid transformation of the American healthcare system that everyone agrees needs to decrease per-capita cost and increase quality.”
Both parts so far have addressed important issues about news media coverage of healthcare. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
October 13th, 2010 by GarySchwitzer in Better Health Network, Expert Interviews, Health Policy, News, Opinion, Video
No Comments »
Next week, the National Press Foundation offers an “all-expenses-paid, educational program on cancer issues” for journalists, with all expenses paid by Pfizer. I’ve written several times about my criticism of this approach.
The National Press Foundation has offered to let me speak at next week’s event or at a subsequent all-expenses-paid program for journalists on Alzheimer’s disease also underwritten by Pfizer.
I’m unable to attend either event because of prior commitments, but suggested to NPF that they ask Merrill Goozner to speak instead. He’s right in Washington, has written and lectured about conflicts of interest in healthcare, and was available. Goozner told me he has not been contacted. So, since I can’t attend and since critical voices probably won’t be represented at the first workshop, I have posted some video clips of what others might have said if given the opportunity. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
